Stem Cell Trial: Umbilical Cord MSCs to Prevent Lung Disease in Preterm Infants
Researchers will test if umbilical cord stem cell infusions can safely reduce lung disease in extremely premature infants.
Pediatric
Longeveron Gains FDA Approval to Begin Phase 2 Stem Cell Trial for Children with Heart Disease
Longeveron will evaluate if it's stem cell candidate, laromestrocel, could target pediatric dilated cardiomyopathy
Stem cell-based alternative to in vitro maturation reports double the pregnancy rate
The company uses iPSCs to create a replica environment for maturing eggs ex vivo, and the data looks promising as they roll into Phase 3.
BrainChild Bio granted FDA RMAT designation for its CAR T-cell therapy for incurable pediatric brain tumors
The company plans on moving to Phase 2 later this year, hopefully supporting a BLA in the near future.
Hope Biosciences launches stem cell trial for children with arthritis (Juvenile Rheumatoid/Idiopathic Arthritis)
Hope Biosciences has reportedly received FDA authorization to conduct a pediatric clinical trial using their adipose(fat)-derived mesenchymal stem cells (HB-adMSCs) to assess their impact on juvenile idiopathic arthritis (JIA) in children aged...